Involvement of calcium-sensing receptor in osteoblastic differentiation of mouse MC3T3-E1 cells. 2005

Mika Yamauchi, and Toru Yamaguchi, and Hiroshi Kaji, and Toshitsugu Sugimoto, and Kazuo Chihara
Dept. of Endocrinology, Metabolism, and Hematological Oncology, Shimane Univ. School of Medicine, 89-1, Enya-cho, Izumo, Shimane, 693-8501, Japan. yamauchi@med.shimane-u.ac.jp

We have previously shown that the extracellular calcium-sensing receptor (CaR) is expressed in various bone marrow-derived cell lines and plays an important role in stimulating their proliferation and chemotaxis. It has also been reported that the CaR modulates matrix production and mineralization in chondrogenic cells. However, it remains unclear whether the CaR plays any role in regulating osteoblast differentiation. In this study, we found that mineralization of the mouse osteoblastic MC3T3-E1 cells was increased when the cells were exposed to high calcium (2.8 and 3.8 mM) or a specific CaR activator, NPS-R467 (1 and 3 microM). Next, we stably transfected MC3T3-E1 cells with either a CaR antisense vector (AS clone) or a vector containing the inactivating R185Q variant of the CaR (DN clone) that has previously been shown to exert a dominant negative action. Alkaline phosphatase activities were decreased compared with controls in both the AS and DN clones. However, the levels of type I procollagen and osteopontin mRNA in the AS clone, as detected by Northern blotting, were almost the same as in the controls. On the other hand, the expression of osteocalcin, which is expressed at a later stage of osteoblastic differentiation, was significantly reduced in both the AS and DN clones. Mineralization was also decreased in both clones. In conclusion, this study showed that the abolition of CaR function results in diminishing alkaline phosphatase activity, osteocalcin expression, and mineralization in mouse osteoblastic cells. This suggests that the CaR may be involved in osteoblastic differentiation.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010006 Osteoblasts Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone. Osteoblast
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002113 Calcification, Physiologic Process by which organic tissue becomes hardened by the physiologic deposit of calcium salts. Bone Mineralization,Calcification, Physiological,Physiologic Calcification,Mineralization, Bone,Physiological Calcification
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D000469 Alkaline Phosphatase An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.

Related Publications

Mika Yamauchi, and Toru Yamaguchi, and Hiroshi Kaji, and Toshitsugu Sugimoto, and Kazuo Chihara
October 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
Mika Yamauchi, and Toru Yamaguchi, and Hiroshi Kaji, and Toshitsugu Sugimoto, and Kazuo Chihara
December 1994, Biochemical and biophysical research communications,
Mika Yamauchi, and Toru Yamaguchi, and Hiroshi Kaji, and Toshitsugu Sugimoto, and Kazuo Chihara
December 2012, Differentiation; research in biological diversity,
Mika Yamauchi, and Toru Yamaguchi, and Hiroshi Kaji, and Toshitsugu Sugimoto, and Kazuo Chihara
January 2007, Biomaterials,
Mika Yamauchi, and Toru Yamaguchi, and Hiroshi Kaji, and Toshitsugu Sugimoto, and Kazuo Chihara
July 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society,
Mika Yamauchi, and Toru Yamaguchi, and Hiroshi Kaji, and Toshitsugu Sugimoto, and Kazuo Chihara
January 2020, International journal of endocrinology,
Mika Yamauchi, and Toru Yamaguchi, and Hiroshi Kaji, and Toshitsugu Sugimoto, and Kazuo Chihara
January 1991, Advances in prostaglandin, thromboxane, and leukotriene research,
Mika Yamauchi, and Toru Yamaguchi, and Hiroshi Kaji, and Toshitsugu Sugimoto, and Kazuo Chihara
July 2016, BMC complementary and alternative medicine,
Mika Yamauchi, and Toru Yamaguchi, and Hiroshi Kaji, and Toshitsugu Sugimoto, and Kazuo Chihara
November 2020, Aging,
Mika Yamauchi, and Toru Yamaguchi, and Hiroshi Kaji, and Toshitsugu Sugimoto, and Kazuo Chihara
December 1998, Biochemical and biophysical research communications,
Copied contents to your clipboard!